Clinical trial · Observational
Risk of Malignancy in Endemic Long Standing Nodular Goitres: a Prospective Cohort Study
NCT06405919CI-TRIAL-00076961completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To determine the incidence of thyroid cancer in patients with long standing goitres presenting for surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Incidence of Thyroid Cancer in Long Standing MNG | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Histopathology | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with goitres 10 years or more
- description
- Patients with long standing multinodular goitres of 10years or more presenting to surgical unit in Khartoum Teaching Hospital -Sudan. Checking incidence of malignancy in this group.
- interventionNames
- Diagnostic Test: Histopathology
Primary outcomes (1)
- measure
- Rate of malignancy
- timeFrame
- March 2017-September 2018
- description
- Rate of malignancy in resected goitre specimens
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All patients with long standing goitres of 10 years or more Exclusion Criteria: * Non
References
Publications (0)
Data not yet available
No reference posted for this study.